The global vascular access device market is experiencing robust expansion as healthcare systems increasingly depend on reliable intravenous access solutions for long-term therapies. The market was valued at USD 6.9 billion in 2024 and is projected to grow from USD 7.3 billion in 2025 to USD 13.8 billion by 2033, registering a compound annual growth rate (CAGR) of 7.8% during the forecast period (2025–2033).

Vascular access devices play a crucial role in modern healthcare by enabling safe and efficient administration of medications, fluids, blood products, and nutritional support directly into the bloodstream. The rising prevalence of chronic diseases such as cancer, diabetes, and kidney disorders, combined with the expanding global geriatric population, is significantly accelerating demand for these devices. Additionally, technological innovations such as antimicrobial coatings, ultrasound-guided placement, and artificial intelligence-assisted insertion systems are improving safety and procedural accuracy.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights!
https://straitsresearch.com/report/vascular-access-device-market/request-sample

Market Drivers

Rising Prevalence of Chronic Diseases Driving Demand

One of the most significant factors propelling the vascular access device market is the increasing global burden of chronic illnesses. Conditions such as cancer, diabetes, and end-stage renal disease (ESRD) frequently require long-term intravenous therapies, making reliable vascular access essential.

According to the World Health Organization (WHO), global cancer cases are expected to rise by more than 75% by 2050, reaching over 35 million new cases annually. Similarly, the U.S. Centers for Disease Control and Prevention (CDC) reported that over 35 million Americans—approximately one in seven adults—live with chronic kidney disease (CKD).

These conditions often require treatments such as chemotherapy, dialysis, and long-term drug administration, all of which depend on dependable vascular access solutions. As healthcare providers focus on improving patient outcomes and treatment efficiency, demand for advanced vascular access devices continues to rise worldwide.

Additionally, the growing adoption of minimally invasive procedures and the expansion of home healthcare services are further increasing the need for durable and easy-to-manage vascular access systems.

Market Challenges

Risk of Catheter-Related Bloodstream Infections (CRBSIs)

Despite their clinical importance, vascular access devices carry certain risks, particularly catheter-related bloodstream infections (CRBSIs). These infections can lead to severe complications, extended hospital stays, and increased healthcare costs.

The CDC estimates that approximately 250,000 CRBSIs occur annually in the United States, highlighting the persistent challenge of infection management associated with catheter use.

These infections are often linked to improper insertion procedures, poor catheter maintenance, or prolonged usage. As a result, healthcare institutions are implementing strict infection control protocols while manufacturers are investing heavily in antimicrobial coatings, improved catheter materials, and safer insertion technologies to reduce these risks.

Market Opportunities

Emerging Markets Offering Significant Growth Potential

Emerging economies are expected to provide substantial growth opportunities for the vascular access device industry. Rising healthcare expenditure, improved medical infrastructure, and increasing awareness of advanced treatment technologies are driving adoption in regions such as Asia-Pacific, Latin America, and parts of the Middle East.

Countries like India and China are witnessing a surge in demand for vascular access devices due to their large patient populations and increasing prevalence of chronic diseases. Government healthcare initiatives, including improved insurance coverage and public healthcare programs, are also accelerating access to advanced medical technologies.

Strategic corporate activities are further strengthening market expansion. For instance, Stryker Corporation announced the $4.9 billion acquisition of Inari Medical in January 2025, aiming to expand its presence in venous disease treatment technologies and strengthen its vascular solutions portfolio in high-growth markets.

Get Full Report with TOC:
https://straitsresearch.com/report/vascular-access-device-market

Regional Insights

North America

North America dominates the global vascular access device market due to its advanced healthcare infrastructure, strong presence of medical device manufacturers, and high prevalence of chronic diseases.

The United States represents the largest contributor in the region, supported by widespread adoption of advanced medical technologies and favorable reimbursement policies. According to the National Cancer Institute, approximately 2 million new cancer cases were projected in the United States in 2024, highlighting the significant demand for vascular access devices used in chemotherapy and long-term treatments.

Canada also demonstrates steady growth, supported by its robust public healthcare system and increasing focus on reducing hospital-acquired infections.

Asia-Pacific

The Asia-Pacific region is expected to be the fastest-growing market during the forecast period. Rapid healthcare infrastructure development, rising medical tourism, and growing healthcare expenditure are key factors supporting this expansion.

China’s healthcare modernization initiatives, including the Healthy China 2030 strategy, are encouraging hospitals to adopt advanced medical devices. Meanwhile, India is witnessing rapid growth due to increasing chronic disease prevalence, improved healthcare access, and government initiatives such as Ayushman Bharat.

Europe

Europe remains a significant market for vascular access devices due to its strong healthcare systems and increasing ageing population. Countries including Germany, the United Kingdom, and France are leading adoption through investments in advanced medical technologies and hospital safety programs.

Germany, in particular, benefits from a strong domestic medical technology industry and increasing emphasis on infection prevention through advanced catheter materials and antimicrobial technologies.

Competitive Landscape

The global vascular access device market is highly competitive, characterized by continuous innovation, mergers and acquisitions, and strategic collaborations among major industry players. Leading companies are focusing on enhancing device safety, improving patient comfort, and reducing infection risks.

Key companies operating in the market include:

• Becton, Dickinson and Company (BD)

• Teleflex Incorporated

• ICU Medical, Inc.

• Braun SE

• AngioDynamics, Inc.

• Medtronic Plc

• Merit Medical Systems Inc.

• Terumo Corporation

• Nipro Medical Corporation

• Vygon SA

• Cook Medical

• Access Vascular, Inc.

• Cordis

• Fresenius Medical Care AG & Co. KGaA

• OrbusNeich

Among these, Becton, Dickinson and Company (BD) remains a dominant market leader due to its extensive global presence and strong product portfolio. The company’s continued investment in research and development and strategic acquisitions, including the acquisition of C.R. Bard, has significantly strengthened its market position.

Market Segmentation

The vascular access device market is segmented based on product type, application, end user, material, and region.

By Product Type

• Central Vascular Access Devices

• Peripherally Inserted Central Catheters (PICC)

• Centrally Inserted Central Catheters

• Implantable Ports

• Peripheral Vascular Access Devices

• Peripheral Intravenous Catheters (PIVC)

• Midline Catheters

• Butterfly/Winged Needles

• Intraosseous Vascular Access Devices

• Accessories

By Application

• Drug Administration

• Fluid & Nutrient Administration

• Blood Transfusion

• Diagnostics & Testing

• Hemodialysis

• Chemotherapy

• Anesthesia

• IV Fluids

By End User

• Hospitals

• Clinics & Ambulatory Care Centres

• Long-Term Care Facilities

• Home Healthcare Settings

By Material

• Polyurethane

• Polyethylene

• Teflon

• Silicone

Recent Developments

Recent strategic developments highlight the growing consolidation and technological innovation within the vascular access device industry.

• January 2025: Stryker announced its $4.9 billion acquisition of Inari Medical, strengthening its portfolio in venous thromboembolism treatment technologies.

• June 2024: Boston Scientific agreed to acquire Silk Road Medical for approximately $1.26 billion, expanding its vascular portfolio with minimally invasive transcarotid artery revascularization technology for stroke prevention.

As healthcare systems worldwide continue to address the growing burden of chronic diseases and prioritize patient safety, the vascular access device market is poised for sustained growth, driven by technological innovation, expanding healthcare access, and the increasing need for reliable long-term intravenous treatment solutions.